Insider Trading Arrangements |
3 Months Ended |
|---|---|
|
Jul. 31, 2026
shares
| |
| Trading Arrangements, by Individual | |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
| Andrew Anagnost [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On May 29, 2026, Andrew Anagnost, our President and Chief Executive Officer terminated his pre-existing Rule 10b5-1 trading arrangement adopted on August 29, 2025 providing for the sale from time to time of an aggregate of up to 93,097 shares of our common stock. On June 23, 2026, Mr. Anagnost, adopted a new Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 66,394 shares of our common stock. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until July 1, 2027, or earlier if all transactions under the trading arrangement are completed.
|
| Andrew Anagnost August 2025 Plan [Member] | Andrew Anagnost [Member] | |
| Trading Arrangements, by Individual | |
| Name | Andrew Anagnost |
| Title | President and Chief Executive Officer |
| Rule 10b5-1 Arrangement Terminated | true |
| Termination Date | May 29, 2026 |
| Aggregate Available | 93,097 |
| Andrew Anagnost June 2026 Plan [Member] | Andrew Anagnost [Member] | |
| Trading Arrangements, by Individual | |
| Name | Andrew Anagnost |
| Title | President and Chief Executive Officer |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | June 23, 2026 |
| Expiration Date | July 1, 2027 |
| Arrangement Duration | 373 days |
| Aggregate Available | 66,394 |